期刊文献+

Avastin前房内注入对治疗新生血管性青光眼的作用 被引量:5

原文传递
导出
摘要 目的 观察Avastin在新生血管性青光眼治疗中的作用。方法随机选择8例新生血管性青光跟患者,前房内注射Avastin,注射后2周视屈光介质情况行周边视网膜冷冻术、视网膜激光光凝术或白内障手术,观察患者虹膜新生血管、视力、眼压变化及角膜内皮细胞计数情况。结果8例患者前房内注射Avastin后3d虹膜新生血管基本消失,4例屈光介质透明的患者进行了全视网膜激光光凝术,4例患者因原有并发性白内障进行了周边视网膜冷冻术,冷冻术后半月2例患者行白内障超声乳化术,手术顺利,随诊6个月,8例患者均有效保存了眼球,眼压控制好,虹膜无新生血管,角膜内皮细胞计数无减少,3例无白内障患者和2例白内障手术患者视力较术前改善。结论Avastin可作为新生血管性青光眼的辅助治疗方法,为新生血管性青光眼的治疗带来新的希望。
出处 《中国实用眼科杂志》 CSCD 北大核心 2009年第1期70-72,共3页 Chinese Journal of Practical Ophthalmology
  • 相关文献

参考文献5

  • 1Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell, 1996,86(3 ):353-364.
  • 2Poltorak Z,Cohen T, Neufeld G. The VEGF splice variants:properties,receptors, and usage for the treatment of ischemic diseases.Herz, 2000,25 ( 2 ) : 126-129.
  • 3Sakaguchi H,Ikuno Y,Gomi F.et al.Intravitreal injection of bevacizumab for choroidal neovascularization caused by pathological myopia.Br J Ophthalmol, 2006,90 : 16.
  • 4孙兴怀.难治性青光眼的治疗[J].国外医学(眼科学分册),1995,19(1):26-31. 被引量:202
  • 5Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al.Systemic bevacizumab (Avastin)therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.Ophthalmology, 2006, 113 ( 11 ) : 2002.1-12.

共引文献201

同被引文献50

  • 1孙兴怀.难治性青光眼及其处理.见:葛坚,孙兴怀,王宁利,主编:现代青光眼研究进展.北京.科学出版社,1999:176.
  • 2Oguri A,Takahashi E,Tomita G,et al.Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma.Ophthalmic Surg Lasers,1998,29:722-727.
  • 3Bloom PA,Tsai JC,Sharma K,et al."Cyclodiode".Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma.Ophtaalmology,1997,104:1508-1519.
  • 4Mermoud A,Salmon JF,Alexander P,et al.Molteno tube implantation for neovascular glaucoma.Long-term Results and factors influencing the outcome.Ophthalmolgy,1993,100897-902.
  • 5Sidoti PA,Dunphy TR,Baerveldt G,et al.Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma.Ophthalmology,1992,102:1107-1118.
  • 6Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil,and leucovorin for metastatic colorectal cancer.N Engl J Med.2004,350:2335-2342.
  • 7Sivack-Callcott JA,O'Day DM,GassDM et al.Evidencebased recommendations for diagnosis and treatment of neovascular glaucoma.Ophthalmology,2001,108:1767-1776.
  • 8Miller KD,Chap LI,Holmes FA,et al.Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.J Clin Oncol,2005,23:792-799.
  • 9Rosenfeld PJ,Fung AE,Puliafito CA.Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.Ophthalmic Surg Lasers Imaging,2005,36:336-339.
  • 10Avery RL,Pieramici DJ,Rabena MD,et al.Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.Ophthalmology,2006,113:363-372.

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部